Article
The breast cancer pro-metastatic phenotype requires concomitant hyper-activation of ECM…
bioRxiv · 2022 · Niccoló Roda
Key facts
| Title | The breast cancer pro-metastatic phenotype requires concomitant hyper-activation of ECM remodeling and dsRNA-IFN1 signaling in rare clone cells |
|---|---|
| First author | Niccoló Roda |
| Journal | bioRxiv |
| Published | Jul 16, 2022 |
| DOI | 10.1101/2022.07.13.499961 |
| Devices mentioned | K013842, K120877, K800781, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184 and 4 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, JPK, KIS and 9 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1